Literature DB >> 6150330

Poliomyelitis in the USA: virtual elimination of disease caused by wild virus.

R J Kim-Farley, K J Bart, L B Schonberger, W A Orenstein, B M Nkowane, A R Hinman, O M Kew, M H Hatch, J E Kaplan.   

Abstract

The average number of paralytic poliomyelitis cases per year in the United States has fallen from 16 000 just before vaccine was introduced in the 1950s to only 12 in 1978-83. 18 of the 69 cases (26%) reported in this 6-year period were not vaccine associated according to the epidemiological classification of paralytic poliomyelitis cases, established in 1975. The van Wezel antigenic differentiation test and oligonucleotide fingerprinting provide a laboratory basis for definitive characterisation of wild and vaccine-like poliovirus strains. Of the 69 cases, isolates from 42 have been analysed; 31 were vaccine-like poliovirus and 11 wild poliovirus. 7 of the wild poliovirus isolates are from cases in a 1979 outbreak caused by poliovirus imported from the Netherlands through Canada; 1 is from a single importation; and 3 are from isolated cases with no identified source. No indigenous wild strain has been isolated from any reported poliomyelitis case since 1981, when a wild strain was isolated from an immunodeficient individual.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150330     DOI: 10.1016/s0140-6736(84)90829-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Trends in adolescent suicide: misclassification bias?

Authors:  B Mohler; F Earls
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  A new paradigm for international disease control: lessons learned from polio eradication in Southeast Asia.

Authors:  J K Andrus; A B Thapa; N Withana; J W Fitzsimmons; P Abeykoon; B Aylward
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 3.  Primary prevention and international travel: infections, immunizations, and antimicrobial prophylaxis.

Authors:  G S Ferenchick; D H Havlichek
Journal:  J Gen Intern Med       Date:  1989 May-Jun       Impact factor: 5.128

Review 4.  Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.

Authors:  A B Sabin
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

5.  Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay.

Authors:  Devasena Gnanashanmugam; Meira S Falkovitz-Halpern; Anthony Dodge; Melanie Fang; Lisa J Wong; Melissa Esparza; Rebecca Hammon; Enrique E Rivas-Merelles; Jose I Santos; Yvonne Maldonado
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

Review 6.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Poliomyelitis in children.

Authors:  B R Santhanakrishnan; N Deivanayagam; E Appachi; A Parthasarathy
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

8.  A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases.

Authors:  R W Sutter; E W Brink; S L Cochi; O M Kew; W A Orenstein; R J Biellik; A R Hinman
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

9.  Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public.

Authors:  Dorothy J Dankel; Kenneth L Roland; Michael Fisher; Karen Brenneman; Ana Delgado; Javier Santander; Chang-Ho Baek; Josephine Clark-Curtiss; Roger Strand; Roy Curtiss
Journal:  Nanoethics       Date:  2014-07-10       Impact factor: 0.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.